MELISSA HALL: Open Payments
NPI 1487075701 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 9 payments from 5 companies in 2025. Trend: 2023 $140 · 2024 $0 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $103 |
| Alkermes, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: INGREZZA, ARISTADA, COBENFY, UZEDY, HETLIOZ.
Industry payments across SC — which companies pay providers there.
